Sensitivity analyses of cost-effectiveness results for HCV treatment for individuals with moderate-severe liver disease (F2-F4) versus no treatment.
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Sensitivity_analyses_of_cost-effectiveness_results_for_HCV_treatment_for_individuals_with_moderate-severe_liver_disease_F2-F4_versus_no_treatment_/8239085
下载链接
链接失效反馈官方服务：
资源简介：
ICER: Incremental cost-effectiveness ratio. QALY: quality adjusted life year. SVR: Sustained viral response.
创建时间：
2019-06-06
